Abhinava K Mishra

9PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsData structures and algorithmsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 06, 2026
Hyperactive Rac converts sublethal to lethal trogocytosis in vivo.

Lauren Penfield, Abhinava K Mishra, Morgan Smith

|Oct 16, 2025
CD47 inhibits phagocytosis through Vav dephosphorylation.

Wyatt D Miller, Andrew Manion, Abhinava K Mishra

|Feb 24, 2025
CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation.

Wyatt D Miller, Abhinava K Mishra, Connor J Sheedy

|Nov 05, 2024
Localized immunotherapy for colitis: breakthroughs with CXCL12-expressing Limosilactobacillus reuteri.

Abhinava K Mishra

|Nov 25, 2023
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond.

Abhinava K Mishra, Ashna Gupta, Gunjan Dagar

|Jun 10, 2023
Analysis and Prediction of COVID-19 Multivariate Data Using Deep Ensemble Learning Methods.

Shruti Sharma, Yogesh Kumar Gupta, Abhinava K Mishra

Pageof 2